ImmunOs Therapeutics AG logo

ImmunOs Therapeutics AG

ImmunOs Therapeutics AG is a pre-clinical biotechnology company focused on discovering and developing first-in-class novel human immunomodulatory proteins against cancer.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://www.immunostherapeutics.com
Founded2015
Disease Focus
Development StagePreclinical
STOCK CODENon Listed
Address
Wagistrasse 14,8952
Schlieren
Switzerland
Email
Contact Number

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/immunos-therapeutics-ag” connections=”true” suffix=””]

ImmunOs Therapeutics has discovered a novel family class of immunomodulators that stimulate the immune system and increase the efficacy of check-point antibodies (CTLA4 + PD-1) in combinatorial therapies. The designed antibodies targets diverse receptors using one molecule to create a synergistic response between immune cells that activate anti-tumor responses.

In Dec 2017, ImmunOs Therapeutics raised 2.3 Mn CHF financing round to advance clinical development.